Vaccine acceptance continues to rise
June 1, 2021
Abacus Data is proud to be supporting the research and polling for the Faster Together Task Group
The number of Canadians willing to be vaccinated is on the rise, and the number of people hesitant or refusing to take a Covid-19 vaccine is at a new low.
Abacus has been providing data on vaccine opinions to a volunteer Task Group of organizations and individuals under the banner “Faster Together”, reminding people that choosing to be vaccinated can bring us all back together again, more quickly. Bruce Anderson, Chairman of Abacus and Hassan Yussuff, President of the Canadian Labour Congress, co-chair the Task Group.
The latest data (collected through 2000 interviews nationwide) show that the number of people who’ve already had a shot or who will take one as soon as it is available to them now stands at 79%, up from 63% only a month ago.
A total of just 21% show some measure of hesitancy, most of whom indicate they can be persuaded to be vaccinated. Just 7% say they will never take a COVID19 shot.
The major factors influencing hesitancy are concern that the long-term impacts of the vaccines may not be known and worries about the risk of blood clots. The proportion of the hesitant who are indicating blood clot concerns is down slightly over recent weeks.
Today, 89% say they would be comfortable taking the Pfizer vaccine, 86% for Moderna, 48% for Johnson and Johnson and 36% for Astra Zeneca.
Hesitancy levels are not equal across different parts of the population. Those exhibiting more hesitancy than average include Albertans, men under 45, those with less formal education. Based on today’s numbers a low-end scenario would see 79% of Canadians vaccinated, and a high-end scenario would see 93% taking the shot.
Peer influence is contributing to the rising acceptance of vaccines. Three out of four (76%) people say that if friends or family asked for advice, they would encourage them to take the shot as soon as possible, while only 6% say they would tell them to refuse.
No doubt contributing to this positive peer-to-peer communication is the fact that for 95% of those who have already had a shot, side effects were not very challenging. The majority (71%) say they had hardly any or no side effects, while another 24% said they were unpleasant but passed quickly.
According to Bruce Anderson: “Vaccine hesitancy is down, community immunity enthusiasm is up. Canadians are hearing from others about only light side effects, and about the benefits of getting to community immunity quickly and as a result, are going out and getting their Covid19 vaccines when offered to them. Barring any unforeseen problems, and with the flow of Pfizer and Moderna vaccines in the weeks ahead, we may see that 14% who remain a bit hesitant, come down further.”
ABOUT FASTER TOGETHER
Overcoming vaccine hesitancy to speed the end of the COVID-19 pandemic in Canada.
This is a voluntary effort of a wide variety of people and organizations working together to promote COVID-19 vaccine acceptance and help speed a recovery from this pandemic. Creative services have been donated by spark*advocacy and research support provided by Abacus Data. Bruce Anderson (spark*advocacy and Abacus) along with Hassan Yussuff, President of the Canadian Labour Congress have been convening a group effort. The current list of participants can be found on our website and is expanding regularly: www.fastertogether.ca
The survey was conducted with 2,000 Canadian adults from May 25-30, 2021.
A random sample of panelists were invited to complete the survey from a set of partner panels based on the Lucid exchange platform. These partners are typically double opt-in survey panels, blended to manage out potential skews in the data from a single source.
The margin of error for a comparable probability-based random sample of the same size is +/- 2.1%, 19 times out of 20. The data were weighted according to census data to ensure that the sample matched Canada’s population according to age, gender, educational attainment, and region. Totals may not add up to 100 due to rounding.
ABOUT ABACUS DATA
We are the only research and strategy firm that helps organizations respond to the disruptive risks and opportunities in a world where demographics and technology are changing more quickly than ever.
Find out more about what we are doing to help clients respond to the COVID-19 pandemic.
We are an innovative, fast-growing public opinion and marketing research consultancy. We use the latest technology, sound science, and deep experience to generate top-flight research-based advice to our clients. We offer global research capacity with a strong focus on customer service, attention to detail and exceptional value.
We were one of the most accurate pollsters conducting research during the 2019 Canadian Election.
Contact us with any questions.
Find out more about how we can help your organization by downloading our corporate profile and service offering.